Medivision Life Sciences Private Limited
About Medivision Life Sciences Private Limited
Data last updated:
Medivision Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 02 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33110KA2011PTC059833. Its GSTIN is 29AAHCM3609H1ZC (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chetana Beekanahalli Vishwaradhya and Jayakumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 39 4th Cross Anubhav Nagar Nagarbhavi Road, Bangalore, Karnataka, India – 560072.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.5 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹7,028 (net margin 0.3%) and EBITDA of ₹37,472 (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo 39 4th Cross Anubhav Nagar Nagarbhavi Road, Bangalore, Karnataka, India – 560072
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medivision Life Sciences Private Limited
The main business activity of Medivision Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medivision Life Sciences Private Limited FY 2025 filings available
Medivision Life Sciences Private Limited reported revenue of ₹22.5 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medivision Life Sciences Private Limited
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medivision Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹37,472 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7,028 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medivision Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medivision Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medivision Life Sciences Private Limited
Medivision Life Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Its own revenue is ₹22.5 Lakh.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Miracle Medilink Private Limited | ₹22.56 Lakh | ₹66,287 | -3% | +45% | Patna, Bihar, India | |
| Samcure Lifescience Private Limited | ₹22.55 Lakh | ₹1.15 Lakh | -5% | -13% | Agra, Uttar Pradesh, India | |
| Vimala Scientific Services Private Limited | ₹22.52 Lakh | ₹47,136 | -2% | +45% | Telangana, India | |
| Anvi Pharmaceuticals Private Limited | ₹22.51 Lakh | ₹56.22 Lakh | -250% | -94% | Mumbai, Maharashtra, India | |
| Faunatech Solutions Private Limited | ₹22.51 Lakh | ₹59.83 Lakh | -266% | +967% | Bangalore, Karnataka, India | |
| Medivision Life Sciences Private Limited this company | ₹22.5 Lakh | ₹7,028 | 0.3% | Bangalore, Karnataka, India | ||
| Sakhi Gruh Private Limited | ₹22.5 Lakh | ₹5,255 | 0% | -28% | Khadana, Gujarat, India | |
| Maaz Naturals Private Limited | ₹22.48 Lakh | ₹42,104 | 2% | +337% | Kattoor, Kerala, India | |
| Laborex Pharma Private Limited | ₹22.48 Lakh | ₹7,866 | 0% | -27% | Mumbai, Maharashtra, India | |
| Aavya Meditech Private Limited | ₹22.48 Lakh | ₹53,121 | 2% | +18% | Noida, Uttar Pradesh, India | |
| Synartis Labs Private Limited | ₹22.46 Lakh | ₹11.21 Lakh | -50% | Srinagarcolony, Telangana, India |
Peers are the five companies nearest above and the five nearest below Medivision Life Sciences by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Figures are as filed with the Ministry of Corporate Affairs or the stock exchanges.
Auditor Details of Medivision Life Sciences Private Limited
Medivision Life Sciences Private Limited is audited by RAGHAVENDRAMAIYA for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAGHAVENDRAMAIYA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medivision Life Sciences Private Limited
Medivision Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetana Beekanahalli Vishwaradhya | Director | 01 Dec 2015 | 10 Years 10 Months | Current |
| Jayakumar | Director | 02 Aug 2011 | 15 Years 2 Months | Current |
Ownership and Shareholding of Medivision Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medivision Life Sciences Private Limited
Medivision Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medivision Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Medivision Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medivision Life Sciences Private Limited
Medivision Life Sciences Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Yogish Bangalore Venkatramanappa ceased to be Director on 21 Dec 2015.
Credit Ratings, Litigation & Regulatory Alerts for Medivision Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medivision Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medivision Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medivision Life Sciences Private Limited
Medivision Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCM3609H1ZC | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medivision Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medivision Life Sciences Private Limited
Medivision Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in chemical products, within the chemicals industry. It was incorporated on 02 August 2011 (15+ years old) and is registered under CIN U33110KA2011PTC059833.
Medivision Life Sciences reported revenue of ₹22.5 Lakh for FY 2025 (up 3% YoY).
Medivision Life Sciences has 2 current directors:
- Chetana Beekanahalli Vishwaradhya - Director
- Jayakumar - Director
Medivision Life Sciences reported a net profit of ₹7,028 (net margin 0.3%) and EBITDA of ₹37,472 (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medivision Life Sciences is 8% over three years and -1% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medivision Life Sciences is 29AAHCM3609H1ZC, registered in Karnataka.
The CIN (Corporate Identification Number) of Medivision Life Sciences is U33110KA2011PTC059833. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medivision Life Sciences was incorporated on 02 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Medivision Life Sciences by revenue are Miracle Medilink Private Limited, Samcure Lifescience Private Limited, Vimala Scientific Services Private Limited, Anvi Pharmaceuticals Private Limited, Faunatech Solutions Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Yogish Bangalore Venkatramanappa ceased to be Director on 21 Dec 2015. Chetana Beekanahalli Vishwaradhya was appointed as Director on 01 Dec 2015. Shankara ceased to be Director on 01 Sep 2011. Medivision Life Sciences has 4 board changes on record in total.
The registered office of Medivision Life Sciences is at No 39 4th Cross Anubhav Nagar Nagarbhavi Road, Bangalore, Karnataka, India – 560072.